Jain Global’s Immunovant IMVT Stock Holding History

Jain Global’s Portfolio IMVT Stock Details IMVT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-26,636	Closed	-$426K	–	1251
2025 Q2	$426K	Buy	+26,636	New	+$403K	﹤0.01%	822
2025 Q1	–	Sell	-10,111	Closed	-$250K	–	1196
2024 Q4	$250K	Buy	+10,111	New	+$287K	0.01%	591

Other funds holding IMVT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TSC

Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return

Jain Global's IMVT Position: Q3 2025 in Review

Jain Global sold out of Immunovant (IMVT) in Q3 2025, closing a stake of 26,636 shares — an estimated $426K sold.

Jain Global first reported a position in IMVT in Q4 2024 and held it in 2 quarters. The position peaked at $426K in Q2 2025. 186 funds tracked by Wall St. Rank hold IMVT as of Q3 2025.

Jain Global reported no remaining Immunovant position as of Q3 2025 after selling out during the quarter.
Jain Global sold 26,636 Immunovant shares in Q3 2025, an estimated $426K.
Jain Global first reported a position in Immunovant in Q4 2024 and held it in 2 quarters.
Jain Global's Immunovant position peaked at $426K in Q2 2025.
186 funds tracked by Wall St. Rank held Immunovant as of Q3 2025.

Based on Jain Global's 13F filing for Q3 2025, filed 14 Nov 2025.